Sitafloxacin and Ertapenem Treatment for Acute Pyelonephritis Caused by Escherichia Coli
Status:
Unknown status
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
The aim of the investigators' study was to evaluate oral and non carbapenem antimicrobial
agents which can be used in outpatient for the treatment of non-bacteremic acute
pyelonephritis caused by Extended Spectrum Beta Lactamase Escherichia coli. This study was
conducted to compare the clinical and bacteriological outcomes of patients with
non-bacteremic acute pyelonephritis caused by Extended Spectrum Beta Lactamase Escherichia
coli who were treated with intravenous (IV) carbapenems followed by oral sitafloxacin or IV
ertapenem.